InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,616.30
(
-0.31%
)
US TECH 100
19,990.00
(
-0.64%
)
Dow Jones
39,740.75
(
0.05%
)
Brent Oil
84.54
(
-0.61%
)
Bitcoin
57,785.30
(
0.05%
)
Post# of 23979
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

LasNubes

Send PM Follow Ignore
Followers 40
Posts 2492
Boards Moderated 0
Alias Born 04/07/2012

LasNubes

Re: None

Tuesday, 02/10/2015 10:31:30 AM

Tuesday, February 10, 2015 10:31:30 AM

Post# of 23979
OREX

...In December 2014, the Committee for Medicinal Products for Human Use (CHMP), the centralized expert advisory committee of the European Medicines Agency, adopted a positive opinion and recommended that the European Commission (EC) grant a centralized marketing authorization through a binding EC decision. The CHMP last week released minutes from their December meeting stating that the positive opinion for Mysimba was adopted by a majority vote with 31 member states in favor and two opposed.


This looks extremely good for approval in Europe in March.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up